Placebo Surgery in Clinical Research Trials for Parkinson Disease

被引:0
|
作者
Dunlop, Susan Rebecca [1 ]
McCormick, Margaret [2 ]
机构
[1] Johns Hopkins Parkinsons Dis & Movement Disorders, Baltimore, MD 21287 USA
[2] Towson Univ, Towson, MD USA
来源
JNP-JOURNAL FOR NURSE PRACTITIONERS | 2015年 / 11卷 / 02期
关键词
Belmont Report; Common Rule; deep brain stimulator; equipoise; ethics; fetal tissue transplantation; Parkinson disease; placebo surgery; SHAM SURGERY;
D O I
10.1016/j.nurpra.2014.07.022
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Advances in the field of neurology and neurosurgery have contributed to the development of novel approaches in the treatment of motor symptoms of Parkinson disease (PD). Comparative trials have been performed in PD to evaluate the efficacy of implanted fetal tissue against the standard of care and placebo surgery. Placebo surgery is when a research subject undergoes a surgical procedure that has the appearance of a therapeutic intervention but during which the essential therapeutic maneuver is omitted and is used as the control arm of the research trial. The purpose of this article is to allow nurse practitioners to review the use of placebo surgery as a control arm in the treatment of PD. The potential of transplantation surgeries to improve the lives of those living with neurodegenerative conditions is a fascinating and promising avenue of medical exploration. An overview of clinical trials in which placebo surgery is used as a control is discussed in this article along with the Common Rule and ethical principles to ensure the protection of human subjects in clinical research.
引用
收藏
页码:240 / 247
页数:8
相关论文
共 50 条
  • [41] Clinical trials in lung cancer surgery and research cooperation
    Zhong, Wen-Zhao
    Zhai, Hao-Ran
    Wu, Yi-Long
    CHINESE CLINICAL ONCOLOGY, 2014, 3 (04)
  • [42] Funding of clinical trials in surgery by the German Research Foundation
    Wissing, F.
    GEFASSCHIRURGIE, 2015, 20 (04): : 266 - 271
  • [43] Apomorphine - pharmacological properties and clinical trials in Parkinson's disease
    Jenner, Peter
    Katzenschlager, Regina
    PARKINSONISM & RELATED DISORDERS, 2016, 33 : S13 - S21
  • [44] Clinical trials aimed at detecting neuroprotection in Parkinson's disease
    Hauser, Robert A.
    Zesiewicz, Theresa A.
    NEUROLOGY, 2006, 66 (10) : S58 - S68
  • [45] New Clinical Trials for Nonmotor Manifestations of Parkinson's Disease
    Schrag, Anette
    Sauerbier, Anna
    Chaudhuri, Kallol Ray
    MOVEMENT DISORDERS, 2015, 30 (11) : 1490 - 1503
  • [46] Gender representation in nonsurgical clinical trials in Parkinson's disease
    Whitney, CM
    Maddux, BN
    Riley, DE
    NEUROLOGY, 2001, 56 (08) : A375 - A376
  • [47] The Linked Clinical Trials initiative (LCT) for Parkinson's disease
    Brundin, Patrik
    Wyse, Richard K.
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2019, 49 (03) : 307 - 315
  • [48] Patterns of outcome measurement in Parkinson's disease clinical trials
    Mitchell, SL
    Harper, DW
    Lau, A
    Bhalla, R
    NEUROEPIDEMIOLOGY, 2000, 19 (02) : 100 - 108
  • [49] Parkinson's disease: From human genetics to clinical trials
    van der Brug, Marcel P.
    Singleton, Andrew
    Gasser, Thomas
    Lewis, Patrick A.
    SCIENCE TRANSLATIONAL MEDICINE, 2015, 7 (305)
  • [50] Results of clinical trials of tiprolisant in narcolepsy and Parkinson's disease
    Arnulf, I.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S204 - S204